H.R.5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018115th Congress (2017-2018) |
|Sponsor:||Rep. Costello, Ryan A. [R-PA-6] (Introduced 03/07/2018)|
|Committees:||House - Energy and Commerce; Judiciary|
|Latest Action:||House - 05/09/2018 Ordered to be Reported by Voice Vote. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.5202 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in House (03/07/2018)
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump.
The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.